{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T01:02:11Z","timestamp":1779757331363,"version":"3.53.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1147531"],"award-info":[{"award-number":["APP1147531"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Manatu Hauora | Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["20-374"],"award-info":[{"award-number":["20-374"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-71094-8","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:14:46Z","timestamp":1774984486000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CXCR3 is associated with T-cell-induced heart damage in acute rheumatic fever"],"prefix":"10.1038","volume":"17","author":[{"given":"Francis M.","family":"Middleton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0684-7635","authenticated-orcid":false,"given":"Reuben","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5480-1714","authenticated-orcid":false,"given":"Natalie","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5177-8420","authenticated-orcid":false,"given":"Sarah","family":"Kilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna E. S.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saem Mul","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciara","family":"Ramiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Tresidder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Serralha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florina","family":"Chan Mow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0775-9581","authenticated-orcid":false,"given":"David I.","family":"Broadhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel J.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna P.","family":"Ralph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel H.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Rod","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Carapetis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6548-637X","authenticated-orcid":false,"given":"Nicole J.","family":"Moreland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"71094_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.84","volume":"2","author":"JR Carapetis","year":"2016","unstructured":"Carapetis, J. R. et al. Acute rheumatic fever and rheumatic heart disease. Nat. Rev. Dis. Primers 2, 1\u201324 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"71094_CR2","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth, G. A. et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J. Am. Coll. Cardiol. 76, 2982\u20133021 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"71094_CR3","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1161\/CIR.0000000000000205","volume":"131","author":"MH Gewitz","year":"2015","unstructured":"Gewitz, M. H. et al. Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation 131, 1806\u20131818 (2015).","journal-title":"Circulation"},{"key":"71094_CR4","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1161\/CIRCULATIONAHA.108.792135","volume":"119","author":"PA Bryant","year":"2009","unstructured":"Bryant, P. A., Robins-Browne, R., Carapetis, J. R. & Curtis, N. Some of the people, some of the time: susceptibility to acute rheumatic fever. Circulation 119, 742\u2013753 (2009).","journal-title":"Circulation"},{"key":"71094_CR5","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3109\/08830185.2014.917411","volume":"33","author":"MW Cunningham","year":"2014","unstructured":"Cunningham, M. W. Rheumatic fever, autoimmunity, and molecular mimicry: the streptococcal connection. Int. Rev. Immunol. 33, 314\u2013329 (2014).","journal-title":"Int. Rev. Immunol."},{"key":"71094_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0140-6736(18)30999-1","volume":"392","author":"G Karthikeyan","year":"2018","unstructured":"Karthikeyan, G. & Guilherme, L. Acute rheumatic fever.  Lancet 392, 161\u2013174 (2018).","journal-title":"Lancet"},{"key":"71094_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1056\/NEJM196409242711301","volume":"271","author":"MH Kaplan","year":"1964","unstructured":"Kaplan, M. H., Bolande, R., Rakita, L. & Blair, J. Presence of bound immunoglobulins and complement in the myocardium in acute rheumatic fever: association with cardiac failure. New Engl. J. Med. 271, 637\u2013645 (1964).","journal-title":"New Engl. J. Med."},{"key":"71094_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1086\/318076","volume":"183","author":"S Roberts","year":"2001","unstructured":"Roberts, S. et al. Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium.  J. Infect. Dis. 183, 507\u2013511 (2001).","journal-title":"J. Infect. Dis."},{"key":"71094_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.919700","volume":"9","author":"CA Kirvan","year":"2023","unstructured":"Kirvan, C. A. et al. IgG2 rules: N-acetyl-\u03b2-D-glucosamine-specific IgG2 and Th17\/Th1 cooperation may promote the pathogenesis of acute rheumatic heart disease and be a biomarker of the autoimmune sequelae of Streptococcus pyogenes. Front. Cardiovasc. Med. 9, 919700 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"71094_CR10","doi-asserted-by":"crossref","unstructured":"McGregor, R. et al. Mapping autoantibodies in children with acute rheumatic fever. Front. Immunol. 12, 702877 (2021).","DOI":"10.3389\/fimmu.2021.702877"},{"key":"71094_CR11","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.4049\/jimmunol.176.9.5662","volume":"176","author":"KC Fa\u00e9","year":"2006","unstructured":"Fa\u00e9, K. C. et al. Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease.  J. Immunol. 176, 5662\u20135670 (2006).","journal-title":"J. Immunol."},{"key":"71094_CR12","doi-asserted-by":"crossref","unstructured":"McGregor, R. et al. PhIP-Seq uncovers marked heterogeneity in acute rheumatic fever autoantibodies. JCI Insight 11, e196619 (2026).","DOI":"10.1172\/jci.insight.196619"},{"key":"71094_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/imcb.12298","volume":"98","author":"AW Chung","year":"2020","unstructured":"Chung, A. W. et al. Systems immunology reveals a linked IgG3\u2013C4 response in patients with acute rheumatic fever. Immunol. Cell Biol. 98, 12\u201321 (2020).","journal-title":"Immunol. Cell Biol."},{"key":"71094_CR14","doi-asserted-by":"crossref","unstructured":"Lorenz, N. et al. An acute rheumatic fever immune signature comprising inflammatory markers, IgG3 and Streptococcus Pyogenes specific antibodies. iScience 27, 110558 (2024).","DOI":"10.1016\/j.isci.2024.110558"},{"key":"71094_CR15","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1161\/CIRCULATIONAHA.121.057301","volume":"145","author":"LS Passos","year":"2022","unstructured":"Passos, L. S. et al. Prothymosin alpha: a novel contributor to estradiol receptor alpha\u2013mediated CD8+ T-cell pathogenic responses and recognition of type 1 collagen in rheumatic heart valve disease. Circulation 145, 531\u2013548 (2022).","journal-title":"Circulation"},{"key":"71094_CR16","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s10753-013-9606-2","volume":"36","author":"KC Fa\u00e9","year":"2013","unstructured":"Fa\u00e9, K. C. et al. CXCL9\/Mig mediates T cells recruitment to valvular tissue lesions of chronic rheumatic heart disease patients. Inflammation 36, 800\u2013811 (2013).","journal-title":"Inflammation"},{"key":"71094_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1161\/01.CIR.92.3.415","volume":"92","author":"L Guilherme","year":"1995","unstructured":"Guilherme, L. et al. Human heart\u2013infiltrating T-Cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation 92, 415\u2013420 (1995).","journal-title":"Circulation"},{"key":"71094_CR18","doi-asserted-by":"publisher","first-page":"5448","DOI":"10.4049\/jimmunol.175.8.5448","volume":"175","author":"NM Ellis","year":"2005","unstructured":"Ellis, N. M., Li, Y., Hildebrand, W., Fischetti, V. A. & Cunningham, M. W. T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease.  J. Immunol. 175, 5448\u20135456 (2005).","journal-title":"J. Immunol."},{"key":"71094_CR19","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.1128\/IAI.69.9.5345-5351.2001","volume":"69","author":"L Guilherme","year":"2001","unstructured":"Guilherme, L. et al. T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients. Infect. Immun. 69, 5345\u20135351 (2001).","journal-title":"Infect. Immun."},{"key":"71094_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.2310\/JIM.0000000000000023","volume":"62","author":"HD Bas","year":"2014","unstructured":"Bas, H. D. et al. A shift in the balance of regulatory T and T helper 17 cells in rheumatic heart disease. J. Investig. Med. 62, 78\u201383 (2014).","journal-title":"J. Investig. Med."},{"key":"71094_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ijcard.2021.02.020","volume":"333","author":"M Ozkaya","year":"2021","unstructured":"Ozkaya, M. et al. The number and activity of CD3+ TCR V\u03b17. 2+ CD161+ cells are increased in children with acute rheumatic fever. Int. J. Cardiol. 333, 174\u2013183 (2021).","journal-title":"Int. J. Cardiol."},{"key":"71094_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/intimm\/dxv063","volume":"28","author":"Y Lai","year":"2016","unstructured":"Lai, Y. & Dong, C. Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases. Int. Immunol. 28, 181\u2013188 (2016).","journal-title":"Int. Immunol."},{"key":"71094_CR23","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1161\/CIRCULATIONAHA.118.033891","volume":"138","author":"ML Kim","year":"2018","unstructured":"Kim, M. L. et al. Dysregulated IL-1\u03b2-GM-CSF axis in acute rheumatic fever that is limited by hydroxychloroquine. Circulation 138, 2648\u20132661 (2018).","journal-title":"Circulation"},{"key":"71094_CR24","doi-asserted-by":"crossref","unstructured":"Middleton, F. M., McGregor, R., Webb, R. H., Wilson, N. J. & Moreland, N. J. Cytokine imbalance in acute rheumatic fever and rheumatic heart disease: mechanisms and therapeutic implications. Autoimmun. Rev. 21, 103209 (2022).","DOI":"10.1016\/j.autrev.2022.103209"},{"key":"71094_CR25","doi-asserted-by":"publisher","first-page":"e053720","DOI":"10.1136\/bmjopen-2021-053720","volume":"11","author":"AP Ralph","year":"2021","unstructured":"Ralph, A. P. et al. Searching for a technology-driven acute rheumatic fever test: the START study protocol. BMJ Open 11, e053720 (2021).","journal-title":"BMJ Open"},{"key":"71094_CR26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1359-6101(02)00020-5","volume":"13","author":"WP Arend","year":"2002","unstructured":"Arend, W. P. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 13, 323\u2013340 (2002).","journal-title":"Cytokine Growth Factor Rev."},{"key":"71094_CR27","doi-asserted-by":"publisher","first-page":"326","DOI":"10.7326\/L15-5126","volume":"163","author":"I Kushner","year":"2015","unstructured":"Kushner, I. & Antonelli, M. J. What should we regard as an \u201celevated\u201d C-reactive protein level? Ann. Intern. Med. 163, 326 (2015).","journal-title":"Ann. Intern. Med."},{"key":"71094_CR28","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.yexcr.2010.12.017","volume":"317","author":"JR Groom","year":"2011","unstructured":"Groom, J. R. & Luster, A. D. CXCR3 in T cell function. Exp. Cell Res. 317, 620\u2013631 (2011).","journal-title":"Exp. Cell Res."},{"key":"71094_CR29","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/clpt.2009.244","volume":"87","author":"B Stuhlm\u00fcller","year":"2010","unstructured":"Stuhlm\u00fcller, B. et al. CD11c as a transcriptional biomarker to predict response to anti-TNF monotherapy with adalimumab in patients with rheumatoid arthritis. Clin. Pharmacol. Ther. 87, 311\u2013321 (2010).","journal-title":"Clin. Pharmacol. Ther."},{"key":"71094_CR30","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1136\/ard.2008.096495","volume":"69","author":"AM Jacobi","year":"2010","unstructured":"Jacobi, A. M. et al. HLA-DRhigh\/CD27high plasmablasts indicate active disease in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 69, 305\u2013308 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"71094_CR31","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41423-019-0244-y","volume":"16","author":"B-x Wu","year":"2019","unstructured":"Wu, B. -x, Zhao, L. -d & Zhang, X. CXCR4 and CXCR5 orchestrate dynamic germinal center reactions and may contribute to the pathogenesis of systemic lupus erythematosus. Cell. Mol. Immunol. 16, 724\u2013726 (2019).","journal-title":"Cell. Mol. Immunol."},{"key":"71094_CR32","doi-asserted-by":"publisher","first-page":"8463","DOI":"10.4049\/jimmunol.179.12.8463","volume":"179","author":"K Mohan","year":"2007","unstructured":"Mohan, K. & Issekutz, T. B. Blockade of chemokine receptor CXCR3 inhibits T cell recruitment to inflamed joints and decreases the severity of adjuvant arthritis.  J. Immunol. 179, 8463\u20138469 (2007).","journal-title":"J. Immunol."},{"key":"71094_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108717","volume":"226","author":"M Yang","year":"2021","unstructured":"Yang, M. et al. An enhanced expression level of CXCR3 on Tfh-like cells from lupus skin lesions rather than lupus peripheral blood. Clin. Immunol. 226, 108717 (2021).","journal-title":"Clin. Immunol."},{"key":"71094_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-28335-3","volume":"13","author":"J Anderson","year":"2022","unstructured":"Anderson, J. et al. Immune signature of acute pharyngitis in a Streptococcus pyogenes human challenge trial. Nat. Commun. 13, 1\u20139 (2022).","journal-title":"Nat. Commun."},{"key":"71094_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155370","volume":"138","author":"JP Tormin","year":"2021","unstructured":"Tormin, J. P. et al. Cytokine gene functional polymorphisms and phenotypic expression as predictors of evolution from latent to clinical rheumatic heart disease. Cytokine 138, 155370 (2021).","journal-title":"Cytokine"},{"key":"71094_CR36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.it.2019.01.005","volume":"40","author":"T Damelang","year":"2019","unstructured":"Damelang, T., Rogerson, S. J., Kent, S. J. & Chung, A. W. Role of IgG3 in infectious diseases. Trends Immunol. 40, 197\u2013211 (2019).","journal-title":"Trends Immunol."},{"key":"71094_CR37","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1172\/JCI41732","volume":"120","author":"M-L Berres","year":"2010","unstructured":"Berres, M.-L. et al. Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice.  J. Clin. Investig. 120, 4129\u20134140 (2010).","journal-title":"J. Clin. Investig."},{"key":"71094_CR38","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/S0002-9440(10)63415-3","volume":"165","author":"L Guilherme","year":"2004","unstructured":"Guilherme, L. et al. Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions.  Am. J. Pathol. 165, 1583\u20131591 (2004).","journal-title":"Am. J. Pathol."},{"key":"71094_CR39","doi-asserted-by":"publisher","first-page":"e0203756","DOI":"10.1371\/journal.pone.0203756","volume":"13","author":"M Shiba","year":"2018","unstructured":"Shiba, M. et al. Presence of increased inflammatory infiltrates accompanied by activated dendritic cells in the left atrium in rheumatic heart disease. PLoS ONE 13, e0203756 (2018).","journal-title":"PLoS ONE"},{"key":"71094_CR40","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/ni.3731","volume":"18","author":"AN Theofilopoulos","year":"2017","unstructured":"Theofilopoulos, A. N., Kono, D. H. & Baccala, R. The multiple pathways to autoimmunity. Nat. Immunol. 18, 716\u2013724 (2017).","journal-title":"Nat. Immunol."},{"key":"71094_CR41","doi-asserted-by":"publisher","first-page":"a028456","DOI":"10.1101\/cshperspect.a028456","volume":"10","author":"T Tanaka","year":"2018","unstructured":"Tanaka, T., Narazaki, M. & Kishimoto, T. Interleukin (IL-6) immunotherapy. Cold Spring Harb. Perspect. Biol. 10, a028456 (2018).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"71094_CR42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","volume":"12","author":"GD Kalliolias","year":"2016","unstructured":"Kalliolias, G. D. & Ivashkiv, L. B. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat. Rev. Rheumatol. 12, 49\u201362 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"71094_CR43","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/rheumatology\/keh437","volume":"44","author":"D Aeberli","year":"2005","unstructured":"Aeberli, D., Seitz, M., J\u00fcni, P. & Villiger, P. Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-\u03b1 inhibitors. Rheumatology 44, 172\u2013175 (2005).","journal-title":"Rheumatology"},{"key":"71094_CR44","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/ecco-jcc\/jjv224","volume":"10","author":"WJ Sandborn","year":"2016","unstructured":"Sandborn, W. J. et al. Eldelumab [anti-IP-10] induction therapy for ulcerative colitis: a randomised, placebo-controlled, phase 2b study. J. Crohn\u2019s Colitis 10, 418\u2013428 (2016).","journal-title":"J. Crohn\u2019s Colitis"},{"key":"71094_CR45","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1136\/gutjnl-2012-303424","volume":"63","author":"L Mayer","year":"2014","unstructured":"Mayer, L. et al. Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study. Gut 63, 442\u2013450 (2014).","journal-title":"Gut"},{"key":"71094_CR46","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1136\/annrheumdis-2012-201310","volume":"72","author":"Y Shirota","year":"2013","unstructured":"Shirota, Y. et al. Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 72, 118\u2013128 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"71094_CR47","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1161\/CIRCRESAHA.124.325652","volume":"136","author":"YV Huang","year":"2025","unstructured":"Huang, Y. V. et al. Novel therapeutic approach targeting CXCR3 to treat immunotherapy myocarditis. Circ. Res. 136, 473\u2013490 (2025).","journal-title":"Circ. Res."},{"key":"71094_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82167-7","volume":"11","author":"T Hasegawa","year":"2021","unstructured":"Hasegawa, T. et al. Inhibition of the CXCL9-CXCR3 axis suppresses the progression of experimental apical periodontitis by blocking macrophage migration and activation. Sci. Rep. 11, 2613 (2021).","journal-title":"Sci. Rep."},{"key":"71094_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2172-13-2","volume":"13","author":"C-H Jenh","year":"2012","unstructured":"Jenh, C.-H. et al. A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection. BMC Immunol. 13, 1\u201314 (2012).","journal-title":"BMC Immunol."},{"key":"71094_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2024.103172","volume":"144","author":"R Lorenzon","year":"2024","unstructured":"Lorenzon, R. et al. The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial. J. Autoimmun. 144, 103172 (2024).","journal-title":"J. Autoimmun."},{"key":"71094_CR51","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1136\/ard-2022-222501","volume":"81","author":"JY Humrich","year":"2022","unstructured":"Humrich, J. Y. et al. Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial. Ann. Rheum. Dis. 81, 1685\u20131694 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"71094_CR52","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","volume":"16","author":"E Schrezenmeier","year":"2020","unstructured":"Schrezenmeier, E. & D\u00f6rner, T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat. Rev. Rheumatol. 16, 155\u2013166 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"71094_CR53","first-page":"3460","volume":"95","author":"FD Goldman","year":"2000","unstructured":"Goldman, F. D. et al. Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties. Blood J. Am. Soc. Hematol. 95, 3460\u20133466 (2000).","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"71094_CR54","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham, H. et al. Welcome to the tidyverse. J. Open Source Softw. 4, 1686 (2019).","journal-title":"J. Open Source Softw."},{"key":"71094_CR55","doi-asserted-by":"publisher","first-page":"e1005752","DOI":"10.1371\/journal.pcbi.1005752","volume":"13","author":"F Rohart","year":"2017","unstructured":"Rohart, F., Gautier, B., Singh, A. & L\u00ea Cao, K.-A. mixOmics: an R package for \u2018omics feature selection and multiple data integration. PLoS Comput. Biol. 13, e1005752 (2017).","journal-title":"PLoS Comput. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71094-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71094-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71094-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:02:24Z","timestamp":1779753744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71094-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["71094"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-71094-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4664"}}